[TS-1: S-1 based chemotherapy for far-advanced or relapsed pancreatic cancer].
Hayashi
Kazuhiko
K
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University.
Uchida
Kazumi
K
Hatori
Takashi
T
Takasaki
Ken
K
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002945:Cisplatin / Q000008:administration & dosage; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D017640:Silicates / Q000008:administration & dosage / Q000627:therapeutic use*; D015996:Survival Rate; D014025:Titanium / Q000008:administration & dosage / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D017640:Silicates; C103828:titanium silicide; D014025:Titanium; D002945:Cisplatin